Industry Publications and Presentations

Realising the Promise of Cancer Vaccines

For years, the promise of therapeutic cancer vaccines has intrigued researchers working in the oncology space. Read our feature article in pharmaphourm by Christopher Oelkrug, Director of Business Development, to learn about the advancements and innovations made in therapeutic cancer vaccine research.

Read More
Compliance Amid the ‘Great Resignation’

Read our Applied Clinical Trials article by Kimberly Wanick, VP of Compliance and Quality, to learn about the cultural changes that need to be made to allow for leaders to place more of an emphasis on employee wellbeing, which can ultimately help reduce disruptions in clinical trials.

Read More
Proactive Planning for Clinical Supply Logistics

In a dynamic clinical trial environment, an innovative, solution-oriented supply chain strategy can ease the startup phase for a trial. In a Pharma Tech Outlook article, Saadia Chaudhry, Director of Clinical Trial Supply Management, shares five key areas that should be paid close attention to when planning your clinical trial supply management (CTSM) strategy.

Read More
Optimizing Patient Recruitment and Engagement Strategies

For decades, the clinical trial industry has struggled with patient recruitment challenges, especially how to efficiently reach a large sample of potential patients. Read our Applied Clinical Trials article by Caroline Redeker, SVP of Corporate Development, and Donna Hanson, Senior Director of Strategy and Optimization, to learn about 5 key strategies that can help you reduce risk and achieve deadlines.

Read More
Optimised Clinical Research Through Decentralised Trials

While the COVID-19 pandemic brought many challenges for life science research and development, it accelerated clinical trial innovation to solve long-standing clinical process issues. Read our feature article in pharmaphorum by Caroline Redeker, SVP of Corporate Development at Advanced Clinical, and Moulik Shah, VP of Digital Health at Advanced Clinical, to learn more.

Read More
Moving Towards Seamless Data Flow in Clinical Trials: Progress in Interoperability

There is a need for seamless data flow throughout the clinical trials ecosystem. Read the PharmaVoice article with Moulik Shah, VP of Digital Health at Advanced Clinical, to learn more.

Read More
Lessons Learned from COVID-19: Why CROs Must Continue Modeling Support and Compassion to Clinical Sites

The COVID pandemic has taught us that compassion is an important attribute that should be modeled amongst clinical research partners and sites to optimize business results. Learn why.

Read More
Decentralised Clinical Trials in Europe: Lessons from a Pandemic

Author: Graham Belgrave, SVP of European Operations at Advanced Clinical. Since the onset of the COVID-19 pandemic, DCTs have been critical to advancing clinical research by minimising in-person interactions. Benefits include the potential to improve recruitment, facilitate data collection, and reduce the need for travel by patients and CRAs alike, resulting in efficiencies and continued profitability. DCTs demand new roles and partnerships which will likely continue long after the pandemic comes under control. Read our feature article in the Journal of Clinical Studies to learn more.

Read More
From telemedicine to remote site visits: the post-COVID face of pharma research and development

The acute phase of the COVID-19 pandemic not only brought delays, restrictions, and reconfigurations to pharmaceutical research & development in 2020, but also a more flexible response to some long-standing issues with the clinical trials process. Read our article, in collaboration with pharmaphorum, to learn more.

Read More
Decentralized Clinical Trials (DCTs): Five Key Questions to Ask Your Partners to Optimize Strategy

This article addresses five essential questions clinical research partners should discuss with sponsors, sites and regulators in order to optimize the strategy and implementation of decentralized and hybrid trial models.

Read More